Search results
Bain Capital Life Sciences invests in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies across the globe, with a focus on companies that both drive medical innovation across the value chain and enable that innovation to improve the lives of patients with unmet medical needs.
Aug 16, 2021 · Newsroom. Bain Capital, LPis one of the world’s leading private investment firms with approximately $185 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live.
Bain Capital Life Sciences seeks to create differentiated value by identifying investments in companies that have these key features: Research organizations that drive innovation across the healthcare value chain.
'Bain Capital Life Sciences led the funding round with participation from Paragon Biosciences, Valor Equity Partners,... 7.12.22. Life Sciences. Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding.
News | Bain Capital Life Sciences. Scroll up to People. See all Life Sciences news >.
Bain Capital Life Sciences specializes in buyouts, inflection capital, growth capital, turnaround investments, and private equity. Boston, Massachusetts, United States. 11-50. Private. www.baincapitallifesciences.com. 149,778. Investments 85. Exits. Unlock for free. Employee Profiles 6. Similar Companies 15. Details. Industries.
Nautilus Biotechnology seeks to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine.
